OMNY Health’s GI partnerships are a pivotal step in its mission to deliver data and insights to accelerate life-changing innovation. With a focus on catalyzing research and improving outcomes, OMNY aims to make a tangible difference for the millions of individuals in...
healthcare
Linking Real-World Clinical Data with Medical Device Data to Demonstrate Device Value
Real-World Data in the Medical Device Market Many life sciences organizations are focused on harnessing real-world data (RWD) capabilities to inform every part of the drug development product life cycle. The same types of RWD can, and should, be applied to innovation...
Social Determinants of Health: Generating Accurate Clinical Insights Using Real-World Data
Recent innovations in healthcare analytics and patient-oriented AI demonstrate the power of leveraging real world data (RWD) to generate ecologically valid actionable insights for life sciences companies to improve patient lives and streamline new therapeutic...
Five Natural Language Processing Subtasks that Large Language Models Can Perform to Improve Healthcare
In late 2022, the technology world was turned upside down as OpenAI released ChatGPT, its new artificial intelligence (AI) model. Unlike most previous natural language processing (NLP) models, this model contained billions of parameters, was trained on a corpus of...
ISPOR Europe 2023: OMNY Health Real-World Data Platform Powering HEOR
HEOR at the Nexus of Policy and Science OMNY Health believes in the importance of a truly transparent, secure, and connected real-world data (RWD) ecosystem to accelerate life-changing care and treatment innovation between providers, patients, and life science...
Practical Applications of FDA’s Guidelines on Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
On August 31, 2023, the U.S. Food and Drug Administration (FDA) released “Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products: Guidance for Industry.”[1] FDA issued this guidance...
OMNY Health Presenting and Exhibiting at ISPOR Annual
Visit the Booth OMNY Health will be presenting and exhibiting at ISPOR Annual on May 7-10, 2023 in Boston, Massachusetts at Booth #1325. Schedule an in-person meeting to learn more about: Clinical measures and social determinants of health data extracted from clinical...
Top Of Mind in Q1 2023
We are nearing the close of Q1 and our provider ecosystem partners have been actively sharing information with us on their key pain points and strategic priorities for this year. Here are the issues they reported as “top of mind” in our latest strategic discussions:...
Atropos Health Expands Evidence Network by Teaming with OMNY Health
Collaboration enables Atropos to generate real-world evidence from OMNY's vast portfolio of data, opening the door for more data-driven medical breakthroughs PALO ALTO, Calif., March 8, 2023 – Atropos Health, a leader in generating personalized real-world...
OMNY Health announces $17 Million Raise to Lead the Next Generation of Real-World Data-Driven Decision-Making and Collaboration Across Healthcare
OMNY Health compliantly connects a diverse network of healthcare stakeholders with research-ready data and insights, significantly reducing the burden of data acquisition and curation, and accelerating the time to decisions and action Atlanta, GA, November 30,...